A pharmacokinetic basis for the efficacy of 4-amino-6-trichloroethenyl-1,3,-benzenedisulfonamide against Fasciola hepatica in the rat.
D000818:Animals; D000980:Antiplatyhelmintic Agents / Q000097:blood / Q000378:metabolism / Q000494:pharmacology*; D002257:Carbonic Anhydrase Inhibitors; D055598:Chemical Phenomena; D002621:Chemistry; D004912:Erythrocytes / Q000201:enzymology; D005210:Fasciola hepatica / Q000187:drug effects* / Q000378:metabolism; D005211:Fascioliasis / Q000188:drug therapy* / Q000378:metabolism; D008099:Liver / Q000378:metabolism; D008297:Male; D051381:Rats; D013449:Sulfonamides / Q000097:blood / Q000378:metabolism / Q000494:pharmacology*; D013737:Testis / Q000378:metabolism; D014241:Trichloroethylene / Q000031:analogs & derivatives / Q000494:pharmacology
D000980:Antiplatyhelmintic Agents; D002257:Carbonic Anhydrase Inhibitors; D013449:Sulfonamides; D014241:Trichloroethylene